- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07643857
Circular Staplers and Anastomotic Leak After Colorectal Surgery (PROTECT)
Prospective Evaluation of the Impact of New Circular Stapler Technology in Colorectal Anastomosis: the PROTECT Study
The goal of this observational study is to evaluate whether different circular stapling devices influence the success of the surgical connection between the bowel ends after colorectal cancer surgery in patients undergoing colorectal resection using different stapling devices.
The main question this study aims to answer is whether different circular stapling devices affect the risk of a leak developing at the site where the bowel is reconnected after colorectal cancer surgery.
Researchers will compare three types of circular stapling devices commonly used in clinical practice (two-row, three-row, and powered circular staplers) to determine whether they are associated with different risks of leakage at the site where the bowel is reconnected after colorectal cancer surgery.
Participants will receive standard medical care. Taking part in this study will not affect their treatment, and no additional procedures, tests, or visits are required as part of the study.
Descripción general del estudio
Estado
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Stefano Agnesi, MD
- Número de teléfono: +390353063612
- Correo electrónico: stefano.agnesi@asst-bergamoest.it
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Adult patients (18 years or older)
- Patients undergoing elective surgery, either open or minimally invasive (laparoscopic or robotic), for anterior rectal resection, sigmoid resection, or left hemicolectomy for colorectal cancer with concomitant colorectal anastomosis (Knight-Griffen technique) using one of the circular stapler types under investigation (two-row CS, three-row CS, PCS).
Exclusion Criteria:
- Patients undergoing emergency surgery
- Patients undergoing additional surgical procedures during the same operation (e.g., cholecystectomy, liver resection, etc.)
- Patients with documented metastases at preoperative staging (cM+)
- Patients under 18 years of age
- Lack of informed consent
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
Patients undergoing colorectal cancer surgery with primary anastomosis
Patients undergoing elective surgery for anterior rectal resection, sigmoid resection, or left hemicolectomy for colorectal cancer with concomitant colorectal anastomosis (Knight-Griffen technique) using one of the circular stapler types under investigation (two-row circular stapler, three-row circular stapler, powered circular stapler).
|
Two-row circular stapler: circular stapling device creating a colorectal anastomosis using two concentric rows of staples.
The device is used according to routine clinical practice during colorectal resection with primary anastomosis.
Three-row circular stapler: circular stapling device creating a colorectal anastomosis using three concentric rows of staples with graduated staple heights designed to optimize tissue compression and sealing.
The device is used according to routine clinical practice during colorectal resection with primary anastomosis.
Powered circular stapler: electrically powered circular stapling device used to create a colorectal anastomosis.
The powered mechanism is designed to standardize tissue compression and stapler firing while reducing operator-dependent variability.
The device is used according to routine clinical practice during colorectal resection with primary anastomosis.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Anastomotic leakage
Periodo de tiempo: From the date of surgery until the first occurrence of anastomotic leakage, assessed up to 30 days after surgery
|
From the date of surgery until the first occurrence of anastomotic leakage, assessed up to 30 days after surgery
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Postoperative complications
Periodo de tiempo: From the date of surgery until the first occurrence of any postoperative complications, assessed up to 30 days after surgery
|
From the date of surgery until the first occurrence of any postoperative complications, assessed up to 30 days after surgery
|
|
Reintervention rate
Periodo de tiempo: From the date of surgery until the first reintervention, assessed up to 30 days after index surgery
|
From the date of surgery until the first reintervention, assessed up to 30 days after index surgery
|
|
Postoperative length of stay
Periodo de tiempo: From date of surgery until the date of hospital discharge, average 1 week
|
From date of surgery until the date of hospital discharge, average 1 week
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- PROTECT study
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .